"We're also have the head of Pfizer here. One of the great businessmen," Trump said. The raucous boos that followed rattled the president, who giggled, then continued going around ...

The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...

Hours after pledging that the safety net program “isn’t going to be touched,” Trump surprised some of his own staff Wednesday ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

Valentina Dabos, lead author of the tracker, said in a statement that the consequences of bankruptcies in healthcare "can be ...

Over 500 pharma executives, lobbyists, consultants and other industry members gathered a couple miles from the White House on ...

Pfizer CEO Albert Bourla said its manufacturing business could be vulnerable from President Donald Trump’s tariffs in Europe ...

In the months after the 2024 election and before President Donald Trump’s second inauguration, healthcare executives paid million of dollars to get the ear of the president.

End-of-year earnings reports reveal drugmakers are grappling with declining vaccination rates and an unpredictable Trump ...

Pfizer is vulnerable to the possibility that President Donald Trump will place tariffs on the European Union, where the ...

The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...